These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 12196818

  • 21. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection.
    Dong JL, Liang BG, Jin YS, Zhang WJ, Wang T.
    Virology; 2005 Sep 01; 339(2):153-63. PubMed ID: 15992851
    [Abstract] [Full Text] [Related]

  • 22. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
    Zhang Q, Su X, Seto D, Zheng BJ, Tian X, Sheng H, Li H, Wang Y, Zhou R.
    Vaccine; 2009 Feb 18; 27(8):1145-53. PubMed ID: 19146906
    [Abstract] [Full Text] [Related]

  • 23. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.
    Shuttleworth G, Eckery DC, Awram P.
    Arch Virol; 2005 Feb 18; 150(2):341-9. PubMed ID: 15578236
    [Abstract] [Full Text] [Related]

  • 24. [Improved expression of human rotavirus VP6 antigen in the recombinant adenoviruse by codon optimization].
    Tong DW, Song JD, Wang JW, Wang M.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec 18; 25(6):420-2. PubMed ID: 22734224
    [Abstract] [Full Text] [Related]

  • 25. [Expression of NA of influenza virus and C3d fusion gene in replication-defective recombinant adenovirus and its immune efficacy analysis].
    Han F, Wang X, Wang Y, Zhao XD, Wu SH.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb 18; 27(1):5-7. PubMed ID: 23855117
    [Abstract] [Full Text] [Related]

  • 26. [Protective efficacy of recombinant rotavirus epitope-based vaccine in mice].
    Liu X, Li JQ, Xiong XY, Chen YN, Peng M, Dai Q, Wen YL, Chen YD.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr 18; 27(2):216-22. PubMed ID: 15960269
    [Abstract] [Full Text] [Related]

  • 27. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery.
    Soler E, Parez N, Passet B, Dubuquoy C, Riffault S, Pillot M, Houdebine LM, Schwartz-Cornil I.
    Vaccine; 2007 Aug 21; 25(34):6373-80. PubMed ID: 17629366
    [Abstract] [Full Text] [Related]

  • 28. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O, Gutierrez-Xicotencatl L, Plett-Torres T, Pedroza-Saavedra A, Gonzalez-Jaimes A, Chihu-Amparan L, Maldonado-Gama M, Espino-Solis G, Bonifaz LC, Esquivel-Guadarrama F.
    Vaccine; 2015 Aug 20; 33(35):4228-37. PubMed ID: 25850020
    [Abstract] [Full Text] [Related]

  • 29. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.
    Agnello D, Hervé CA, Lavaux A, Darniot M, Guillon P, Charpilienne A, Pothier P.
    J Virol; 2006 Apr 20; 80(8):3823-32. PubMed ID: 16571799
    [Abstract] [Full Text] [Related]

  • 30. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles.
    Ogier A, Franco MA, Charpilienne A, Cohen J, Pothier P, Kohli E.
    Eur J Immunol; 2005 Jul 20; 35(7):2122-30. PubMed ID: 15948217
    [Abstract] [Full Text] [Related]

  • 31. Baculovirus expression of the ADRV gene 5 encoded protein produces an oligomerized, antigenic, and immunogenic VP6 protein.
    Mackow ER, Fay ME, Werner-Eckert R, Hung T, Wang ZJ, Chen G.
    Virology; 1993 Mar 20; 193(1):537-42. PubMed ID: 8382412
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of a bovine rotavirus VP6 vaccine efficacy in the calf model of infection and disease.
    Gonzalez DD, Mozgovoj MV, Bellido D, Rodriguez DV, Fernandez FM, Wigdorovitz A, Parreño VG, Dus Santos MJ.
    Vet Immunol Immunopathol; 2010 Sep 15; 137(1-2):155-60. PubMed ID: 20546933
    [Abstract] [Full Text] [Related]

  • 33. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants.
    Yang Y, Li X, Yang H, Qian Y, Zhang Y, Fang R, Chen X.
    Sci China Life Sci; 2011 Jan 15; 54(1):82-9. PubMed ID: 21104033
    [Abstract] [Full Text] [Related]

  • 34. [Construction of a recombinant human adenovirus expressing the ORF2 antigen of HEV and immunization of mice by mucosal system].
    Dong X, Hu JY, Xie TH, Sun MS, Dai CB, Ma YB.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun 15; 25(3):324-8. PubMed ID: 12905749
    [Abstract] [Full Text] [Related]

  • 35. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
    Li Z, Cui K, Huang K, Liu F, Shi D, Liu Q.
    Protein Pept Lett; 2019 Jun 15; 26(12):904-909. PubMed ID: 31429685
    [Abstract] [Full Text] [Related]

  • 36. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice.
    Jiang W, Jiang P, Li Y, Tang J, Wang X, Ma S.
    Vet Immunol Immunopathol; 2006 Sep 15; 113(1-2):169-80. PubMed ID: 16777236
    [Abstract] [Full Text] [Related]

  • 37. [Construction and identification of recombinant adenovirus vector containing thioredoxin reductase gene].
    Xu JY, Xu L, Peng GY, Ding CL, Lu SY, Yao K.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep 15; 19(5):440-2. PubMed ID: 15169650
    [Abstract] [Full Text] [Related]

  • 38. Expression and characterization of human group C rotavirus virus-like particles in insect cells.
    Clark KB, Lin SC, Humphrey C, Foytich K, Esona M, Wang Y, Liu M, Jiang B.
    Virology; 2009 May 10; 387(2):267-72. PubMed ID: 19285329
    [Abstract] [Full Text] [Related]

  • 39. Molecular cloning and immunogenicity evaluation of rotavirus structural proteins as candidate vaccine.
    El-Senousy WM, Shahein YE, Barakat AB, Ghanem HE, El-Hakim AE, Ameen SM.
    Int J Biol Macromol; 2013 Aug 10; 59():67-71. PubMed ID: 23588003
    [Abstract] [Full Text] [Related]

  • 40. VP6: A candidate rotavirus vaccine.
    Ward RL, McNeal MM.
    J Infect Dis; 2010 Sep 01; 202 Suppl():S101-7. PubMed ID: 20684688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.